The estimated Net Worth of Essra Ridha is at least 46 千$ dollars as of 1 February 2024. Dr Ridha owns over 32,834 units of AvroBio Inc stock worth over 45,968$ and over the last 3 years he sold AVRO stock worth over 0$.
Sign up
Dr D AVRO stock SEC Form 4 insiders trading
Dr has made over 1 trades of the AvroBio Inc stock since 2024, according to the Form 4 filled with the SEC. Most recently he exercised 32,834 units of AVRO stock worth 45,968$ on 1 February 2024.
The largest trade he's ever made was exercising 32,834 units of AvroBio Inc stock on 1 February 2024 worth over 45,968$. On average, Dr trades about 6,567 units every 0 days since 2021. As of 1 February 2024 he still owns at least 32,834 units of AvroBio Inc stock.
You can see the complete history of Dr Ridha stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Dr. Essra Ridha FFPM, M.D. biography
Dr. Essra Ridha FFPM, M.D. is the Chief Medical Officer at AvroBio Inc.
What's Dr D's mailing address?
Essra's mailing address filed with the SEC is C/O AVROBIO, INC., 100 TECHNOLOGY SQUARE, 6TH FLOOR, CAMBRIDGE, MA, 02139.
Insiders trading at AvroBio Inc
Over the last 6 years, insiders at AvroBio Inc have traded over 3,066,308$ worth of AvroBio Inc stock and bought 2,395,057 units worth 31,037,133$ . The most active insiders traders include Braden Michael Leonard、Bruce Booth、Venture Fund X, L.P.Atlas V.... On average, AvroBio Inc executives and independent directors trade stock every 102 days with the average trade being worth of 206,675$. The most recent stock trade was executed by Braden Michael Leonard on 13 May 2024, trading 766,635 units of AVRO stock currently worth 973,626$.
What does AvroBio Inc do?
clinical stage company focused on delivering step-change cell & gene therapies targeting cancer and rare disease.
What does AvroBio Inc's logo look like?
Complete history of Dr Ridha stock trades at AvroBio Inc
AvroBio Inc executives and stock owners
AvroBio Inc executives and other stock owners filed with the SEC include:
-
Birgitte Volck,
President - Research & Development -
Erik Ostrowski,
Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer, Treasurer -
Geoff MacKay,
President, Chief Executive Officer, Director -
Steven Avruch,
Secretary, Chief Legal Officer -
Geoff MacKay BSc,
Co- Founder, Pres, CEO & Director -
Geoff MacKay,
Co- Founder, Pres, CEO & Director -
Erik Ostrowski M.B.A.,
CFO & Treasurer -
Steven N. Avruch J.D.,
Chief Legal Officer & Sec. -
Philip Vickers,
Independent Director -
Bruce Booth,
Independent Chairman of the Board -
Christopher Paige,
Independent Director -
Phillip Donenberg,
Independent Director -
Annalisa Jenkins,
Independent Director -
Ian Clark,
Independent Director -
Gail Farfel,
Director -
Kim Raineri,
Chief Manufacturing and Technology Officer -
Chris Brinzey,
IR Contact Officer -
Deanna Petersen,
Chief Business Officer -
Dr. Essra Ridha FFPM, M.D.,
Chief Medical Officer -
Andreas Kouri,
Sr. VP of Global Supply Chain & External Manufacturing -
Azadeh Golipour Ph.D.,
Chief Technology Officer -
Deanna M. Petersen MBA,
Chief Bus. Officer -
Dr. Christopher Mason FMEDSCI, FRCS, M.D., Ph.D.,
Chief Scientific Officer -
Dr. Christopher Mason FMEDSCI, M.D., Ph.D., FRCS,
Chief Scientific Officer -
Deanna M. Petersen M.B.A., MBA,
Chief Bus. Officer -
Georgette Verdin,
Chief HR Officer -
Monique Da Silva,
Sr. VP of Corp. Communications -
Dr. Christopher Mason,
Chief Scientific Officer -
Kim Raineri M.B.A.,
Chief Manufacturing & Technology Officer -
Matthew Arnold,
Head of Operations -
Jeffrey Medin Ph.D.,
Scientific Founder -
Venture Fund X, L.P.Atlas V...,
-
Lifesciences Iii, L.P.Claru...,
-
Scott Requadt,
Director -
Vi, Llcsv Life Sciences Fun...,
-
Katina Dorton,
Chief Financial Officer -
Nerissa Kreher,
Chief Medical Officer -
Venture Associates X, L.P. ...,
10% owner -
Lifesciences Iii, L.P.Claru...,
-
Diana Escolar,
Chief Medical Officer -
Christopher Mason,
Chief Scientific Officer -
Essra Ridha,
Chief Medical Officer -
Azadeh Golipour,
Chief Technology Officer -
Braden Michael Leonard,